Notably, cells derived from advanced metastatic lesions exhibited a more pronounced phenotype, characterized by significantly lower levels of three key repressor proteins, PTCH1, SUFU, and GLI3, compared to primary melanoma cells. Here, PTCH1 is linked to melanoma.